Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for the second quarter of 2025.
- On a reported basis, second-quarter earnings were $0.46 per share, compared to $0.45 in the same period a year ago
- Adjusted earnings per share from continuing operations dropped to $1.18 from $1.22 a year earlier
- Second-quarter revenue increased to about $720 million from $692 million in the prior-year quarter
- Life Sciences revenues increased 5% annually to $366 million in the second quarter; Diagnostics revenue rose 3% to $354 million
- Operating income from continuing operations, on a reported basis, was $91 million, vs. $86 million in Q2 FY24
- For the full year 2025, the company raised its full-year revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates; it assumes 2% to 4% organic growth
- The management also updated its adjusted earnings per share guidance to a range of $4.85 to $4.95
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
